Relative risk factors associated with the development of fundic gland polyps

European Journal of Gastroenterology and Hepatology

Volumn 26, Issue 11, 2014, Pages 1217-1221

  Huang, Can Ze ^a   Lai, Ren Xu ^a   Mai, Lei ^a   Zhou, Huai Li ^a   Chen, Hong Jiang ^a   Guo, Hui Xue ^a  

^a THE FIFTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Endoscopy; Fundic gland polyps; Polyps; Proton pump inhibitors

Indexed keywords

ESOMEPRAZOLE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; RABEPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOSCOPY; FEMALE; HELICOBACTER INFECTION; HUMAN; INFORMATION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; STOMACH POLYP; AGE; CHEMICALLY INDUCED; CHINA; COMPLICATION; DRUG ADMINISTRATION; DRUG UTILIZATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; MICROBIOLOGY; MIDDLE AGED; POLYPS; STATISTICS AND NUMERICAL DATA; STOMACH FUNDUS; STOMACH NEOPLASMS;

ADULT; AGE FACTORS; CHINA; DRUG ADMINISTRATION SCHEDULE; DRUG UTILIZATION; FEMALE; GASTRIC FUNDUS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; POLYPS; PREVALENCE; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES; RISK FACTORS; STOMACH NEOPLASMS;

EID: 84927585311     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0000000000000199     Document Type: Article

References (30)

1. Wang H, Xu L. Clinical characteristics of 365 gastric polyps. Clin Med Chin 2010; 26:581-584.
2. Borch K, Skarsgård J, Franzén L, Mårdh S, Rehfeld JF. Benign gastric polyps: morphological and functional origin. Dig Dis Sci 2003; 48:1292-1297.
3. Carmack SW, Genta RM, Schuler C.M., Saboorian MH. The current spectrum of gastric polyps: a 1-year national study of over 120 000 patients. Am J Gastroenterol 2009; 104:1524-1532.
4. Ally MR, Veerappan GR, Maydonovitch C.L., Duncan TJ, Perry JL, Osgard EM, Wong RK. Chronic proton pump inhibitor therapy associated with increased development of fundic gland polyps. Dig Dis Sci 2009; 54:2617-2622.
5. Genta RM, Schuler CM, Robiou C.I., Lash RH. No association between gastric fundic gland polyps and gastrointestinal neoplasia in a study of over 100 000 patients. Clin Gastroenterol Hepatol 2009; 7:849-854.
6. Zelter A, Fernández JL, Bilder C., Rodríguez P, Wonaga A., Dorado F, et al. Fundic gland polyps and association with proton pump inhibitor intake: a prospective study in 1780 endoscopies. Dig Dis Sci 2011; 56:1743-1748.
7. Hongo M, Fujimoto K. Gastric Polyps Study Group. Incidence and risk factor of fundic gland polyp and hyperplastic polyp in long-term proton pump inhibitor therapy: a prospective study in Japan. J Gastroenterol 2010; 45:618-624.
8. Jalving M, Koornstra JJ, Wesseling J, Boezen H.M., de Jong S, Kleibeuker JH. Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy. Aliment Pharmacol Ther 2006; 24:1341-1348.
9. Vieth M, Stolte M. Fundic gland polyps are not induced by proton pump inhibitor therapy. Am J Clin Pathol 2001; 116:716-720.
10. García-Alonso F.J., Martín-Mateos RM, González Martín JA, Foruny JR, Vázquez-Sequeiros E, Boixeda de Miquel D. Gastric polyps: analysis of endoscopic and histological features in our center. Rev Esp Enferm Dig 2011; 103:416-420.
11. Freeman HJ. Proton pump inhibitors and an emerging epidemic of gastric fundic gland polyposis. World J Gastroenterol 2008; 14:1318-1320.
12. Graham JR. Gastric polyposis: onset during long-term therapy with omeprazole. Med J Aust 1992; 157:287-288.
13. Kinoshita Y, Tojo M, Yano T., Kitajima N, Itoh T, Nishiyama K., et al. Incidence of fundic gland polyps in patients without familial adenomatous polyposis. Gastrointest Endosc 1993; 39:161-163.
14. Marcial MA, Villafaña M, Hernandez-Denton J, Colon-Pagan JR. Fundic gland polyps: prevalence and clinicopathologic features. Am J Gastroenterol 1993; 88:1711-1713.
15. Torbenson M, Lee JH, Cruz-Correa M, Ravich W., Rastgar K, Abraham SC, Wu TT. Sporadic fundic gland polyposis: a clinical, histological, and molecular analysis. Mod Pathol 2002; 15:718-723.
16. Fossmark R, Jianu CS, Martinsen T.C., Qvigstad G., Syversen U, Waldum HL. Serum gastrin and chromogranin A levels in patients with fundic gland polyps caused by long-term proton-pump inhibition. Scand J Gastroenterol 2008; 43:20-24.
17. Masaoka T, Suzuki H, Hibi T. Gastric epithelial cell modality and proton pump inhibitor. J Clin Biochem Nutr 2008; 42:191-196.
18. Koh TJ, Chen D. Gastrin as a growth factor in the gastrointestinal tract. Regul Pept 2000; 93:37-44.
19. Synnerstad I, Holm L. Omeprazole induces high intraglandular pressure in the rat gastric mucosa. Gastroenterology 1997; 112:1221-1230.
20. Cats A, Schenk BE, Bloemena E, Roosedaal R., Lindeman J, Biemond I, et al. Parietal cell protrusions and fundic gland cysts during omeprazole maintenance treatment. Hum Pathol 2000; 31:684-690.
21. Krishnamurthy S, Dayal Y. Parietal cell protrusions in gastric ulcer disease. Hum Pathol 1997; 28:1126-1130.
22. Yamamoto A, Ishiguro H, Kondo T., Naruse S, Goto H. Low prevalence of Helicobacter pylori infection in patients with fundic gland polyps. Nihon Rinsho 2005; 63:621-624.
23. Shand AG, Taylor AC, Banerjee M, Lessels A., Coia J, Clark C, et al. Gastric fundic gland polyps in south-east Scotland: absence of adenomatous polyposis coli gene mutations and a strikingly low prevalence of Helicobacter pylori infection. J Gastroenterol Hepatol 2002; 17:1161-1164.
24. Thomson AB, Sauve MD, Kassam N, Kamitakahara H. Safety of the longterm use of proton pump inhibitors. World J Gastroenterol 2010; 16:2323-2330.
25. Watanabe N, Seno H, Nakajima T., Yazumi S, Miyamoto S, Matsumoto S., et al. Regression of fundic gland polyps following acquisition of Helicobacter pylori. Gut 2002; 51:742-745.
26. Oberhuber G, Stolte M. Gastric polyps: an update of their pathology and biological significance. Virchows Arch 2000; 437:581-590.
27. Hofgärtner WT, Thorp M, Ramus M.W., Delorefice G., Chey WY, Ryan CK, et al. Gastric adenocarcinoma associated with fundic gland polyps in a patient with attenuated familial adenomatous polyposis. Am J Gastroenterol 1999; 94:2275-2281.
28. Zwick A, Munir M, Ryan C.K., Gian J., Burt RW, Leppert M, et al. Gastric adenocarcinoma and dysplasia in fundic gland polyps of a patient with attenuated adenomatous polyposis coli. Gastroenterology 1997; 113:659-663.
29. Hagiwara T, Mukaisho K, Nakayama T., Sugihara H, Hattori T. Long-term proton pump inhibitor administration worsens atrophic corpus gastritis and promotes adenocarcinoma development in Mongolian gerbils infected with Helicobacter pylori. Gut 2011; 60:624-630.
30. Jalving M, Koornstra JJ, Götz JM, van der Waaij LA, de Jong S, Zwart N, et al. High-grade dysplasia in sporadic fundic gland polyps: a case report and review of the literature. Eur J Gastroenterol Hepatol 2003; 15:1229-1233.